The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
AIMS: The role of vascular endothelial growth factor (VEGF-A) in atherogenesis has remained controversial. We addressed this by comparing the effects of adenoviral VEGF-A gene transfer on atherosclerosis and lipoproteins in ApoE(-/-), LDLR(-/-), LDLR(-/-)ApoE(-/-), and LDLR(-/-)ApoB(100/100) mice. METHODS AND RESULTS: After 4 weeks on western diet, systemic adenoviral gene transfer was performed with hVEGF-A or control vectors. Effects on atherosclerotic lesion area and composition, lipoprotein profiles, and plasma lipoprotein lipase (LPL) activity were examined. On day 4, VEGF-A induced alterations in lipoprotein profiles and a significant negative correlation was observed between plasma LPL activity and VEGF-A levels. One month after gene transfer, no changes in atherosclerosis were observed in LDLR(-/-) and LDLR(-/-)ApoB(100/100) models, whereas both ApoE(-/-) models displayed increased en face lesion areas in thoracic and abdominal aortas. VEGF-A also reduced LPL mRNA in heart and white adipose tissue, whereas Angptl4 was increased, potentially providing further mechanistic explanation for the findings. CONCLUSION: VEGF-A gene transfer induced pro-atherogenic changes in lipoprotein profiles in all models. As a novel finding, VEGF-A also reduced LPL activity, which might underlie the observed changes in lipid profiles. However, VEGF-A was observed to increase atherosclerosis only in the ApoE(-/-) background, clearly indicating some mouse model-specific effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481 · cited 3×
“On day 4, both AdLacZ and AdVEGF-A caused a general increase in plasma lipid levels, which most likely reflects the acute-phase inflammatory response to adenovirus.(13) No statistical differences in plasma lipids between AdLacZ and AdVEGF-A were seen in the atherosclerosis-prone models.”
InfluentialVascular endothelial growth factor enhances atherosclerotic plaque progression
Celletti, F. L., Waugh, J. M., Amabile, P. G., Brendolan, A., Hilfiker, P. R., & Dake, M. D. (2001) · Nature Medicine · doi:10.1038/86490 · Cited by 708 · cited 1×
“In ApoE mice, VEGF-A has reported to be pro-atherogenic via increased plaque angiogenesis.(6) However, this was not seen in our previous study with LDLRApoB mice and systemic AdVEGF-A administration.”
BackgroundKöster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0476 · Cited by 427 · cited 1×
“It has been shown that Angptl4 deficiency in mice leads to increased levels of heparin-releasable LPL activity and decreased plasma triglyceride levels, whereas overexpression of Angptl4 decreases LPL activity and increases plasma triglycerides.(23)”
BackgroundNordestgaard, B. G., Abildgaard, S., Wittrup, H. H., Steffensen, R., Jensen, G., & Tybjærg-Hansen, A. (1997) · Circulation · doi:10.1161/01.cir.96.6.1737 · Cited by 146 · cited 1×
“This is not unexpected, since in human subjects heterozygous for the LPL gene, 30–50% decrease in LPL activity causesonly modestly elevated concentrations of plasma triglycerides and even no changes in total cholesterol.(24,25) On the other hand, it also suggests that the reduction in LPL activity was unlikely to play…”
Background
Cited by
Angiogenesis in the atherosclerotic plaque
Camaré, C., Pucelle, M., Nègre-Salvayre, A., & Salvayre, R. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.007 · Cited by 401
Hall, S., & Agrawal, D. K. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0409-0 · Cited by 20
Zhao, C., Miao, D., Tan, D., Shi, J., Lv, Q., Xiong, Z., & Zhang, X. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2911390 · Cited by 6
Metadata
- Authors
- Heinonen, S. E., Kivelä, A. M., Huusko, J., Dijkstra, M. H., Gurzeler, E., Mäkinen, P. I., Leppänen, P., Olkkonen, V. M., Eriksson, U., Jauhiainen, M., & Ylä-Herttuala, S.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-06-10
- Volume
- 99
- Issue
- 4
- Pages
- 716-723
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W2176794623
- Cited by
- 61
- References
- 4
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models. https://app.cochat.ai/papers/10.1093/cvr/cvt148
- The paper
- Heinonen, S. E., Kivelä, A. M., Huusko, J., Dijkstra, M. H., Gurzeler, E., Mäkinen, P. I., Leppänen, P., Olkkonen, V. M., Eriksson, U., Jauhiainen, M., & Ylä-Herttuala, S. (2013). The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models. Cardiovascular Research. https://doi.org/10.1093/cvr/cvt148
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.